Sixue Zhang, Ph.D.

Head of A.I. Drug Discovery

Sixue Zhang, Ph.D., has more than 10 years of experience in computer-aided drug discovery. He obtained a Ph.D. of computational chemistry at the University of Illinois Urbana-Champaign with the J. & M. Witt Fellowship under the supervision of Prof. Sharon Hammes-Schiffer. Since joining Southern Research, Dr. Zhang has collaborated with more than 20 multidisciplinary teams from both academia and industry for more than 50 drug discovery projects covering oncology, neurology, infectious diseases, and other therapeutic areas.

His team is part of Southern Research’s integrated Design-Make-Test-Analyze drug discovery platform. His team leverages latest artificial intelligence and next-generation molecular modeling technology to facilitate drug discovery pipelines from therapeutic target discovery all the way to clinical stage. For example, aided by AI models developed with vast in-house assay data, his team quickly discovered highly potent novel antiviral inhibitors that otherwise would take years to discover. Besides, Dr. Zhang serves in editorial board of scientific journals, professional committees, as well as speakers in national and international conferences.

Related Articles

Southern Research leader Augelli-Szafran named 2024 National Academy of Inventors Fellow 

December 11, 2024

Southern Research leader Augelli-Szafran named 2024 National Academy of Inventors Fellow     BIRMINGHAM, AL. December 11, 2...
Read More

Biotech incubator Station 41 fills up with plans to expand

November 21, 2024

Southern Research's biotech incubator, Station 41 fills up with plans to expand. The pilot space for the Incubator was unveiled in January 2024 with twelve private leasable wet labs (325-625 square feet) and 13 private offices (125-200 sq. ft.). “We...
Read More

MyOme and Broad Clinical Labs to support Southern Research program to bring genetics-driven health insights to Alabamians free of charge

October 14, 2024

MyOme, Inc., a leading clinical genetics innovation company, and Broad Clinical Labs (BCL), a world expert in whole genome sequencing (WGS) are announcing a collaboration to support the Southern Research (SR) program, Catalyst. SR is a leading nonprofit research organization committed to advancin...
Read More